FDA
- Status: approved
Bryophyllum 50 % Chewing Tablets (Bryophyllum 50 % Chewing Tablets) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Markus Schlemmer is the originator. The local marketing authorisation holder may differ — check the official source linked above.